MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Clinical trials for MALIGNANT PERIPHERAL NERVE SHEATH TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT PERIPHERAL NERVE SHEATH TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT PERIPHERAL NERVE SHEATH TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to halt Cancer's deadly spread
Disease control Recruiting nowThis early-phase trial tests a new drug called metarrestin in people with advanced solid tumors that have spread. The goal is to find a safe dose and see if it can shrink tumors or stop them from growing further. The study includes adults with pancreatic, breast, or other solid t…
Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Blood test could spot rare cancer in NF1 patients years earlier
Knowledge-focused Recruiting nowThis study looks at whether a blood test (liquid biopsy) can find a rare cancer called MPNST earlier than current methods in adults with Neurofibromatosis Type 1 (NF1). About 1,000 participants will give blood samples and complete surveys every six months for five years. The goal…
Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Sponsor: David Miller • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC